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Abstract: The immunogenic potential of α-gliadin protein from two ancient wheats was 
studied with reference to coeliac disease. To this aim we investigated Graziella Ra® and 
Kamut® (the latter is considered an ancient relative of modern durum wheat) in 
comparison to four durum wheat accessions (Senatore Cappelli, Flaminio, Grazia and 
Svevo). ELISA and Western Blot analyses - carried out by two monoclonal antibodies 
raised against the α-gliadin peptides p31-49 (LGQQQPFPQQPYPQPQPF) and p56-75 
(LQLQPFPQPQLPYPQPQLPY) containing a core region (underlined) reported to be toxic 
for coeliac patients - always showed an antibody-antigen positive reaction. For all 
accessions, an α-gliadin gene has also been cloned and sequenced. Deduced amino acid 
sequences constantly showed the toxic motifs. In conclusion, we strongly recommend that 
coeliac patients should avoid consuming Graziella Ra® or Kamut®. In fact their α-gliadin 
not only is as toxic as one of the other wheat accessions, but also occurs in greater amount, 
which is in line with the higher level of proteins in ancient wheats when compared to 
modern varieties. 
Keywords:  coeliac disease; ancient wheats; α-gliadin; toxic peptides; monoclonal 
antibodies; Triticum turgidum durum 
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1. Introduction  
 
Wheat is an important staple food because of its characteristics such as the high nutritional value, 
technical properties and the long life of the kernels. Commonly used varieties belong to tetraploid 
(Triticum turgidum durum, pasta wheat) or hexaploid (Triticum aestivum, bread wheat) species 
originating from natural hybridizations between diploid ancestors thousands of years ago. Wheat 
endosperm contains 8–15% of proteins, of which 80% is gluten whose components are gliadins and 
glutenins, each one having peptides able to induce coeliac disease (CD), an intestinal chronic disorder 
caused by an intolerance to gluten proteins, mainly resulting in small-intestinal mucosal injuries and 
nutrient malabsorption in susceptible individuals [1]. The only effective treatment available for CD 
patients is a strict exclusion of gluten from their diet. The detrimental consequences of gluten and/or 
analogous proteins (present in rye, barley and oats) consumption are well documented, showing that 
noncompliance to a gluten-free diet is associated with increased risk of anemia, infertility, osteoporosis 
and intestinal lymphoma [2]. In recent years it has become clear that CD is far more common than 
previously thought. Several serological screening studies from Europe, South America, Australasia 
and the USA have shown that approximately 0.5–1% of these populations suffer from CD. 
Nevertheless, most affected individuals remain undiagnosed due to an increasingly broad spectrum of 
clinical presentations [3]. Moreover, CD is a multifactorial disorder including both genetic and 
environmental factors whose relative weight is not yet fully understood. Differences in concordance 
rates in monozygotic (86%) and dizygotic (20%) twins strongly suggest a relevant influence of genetic 
factors, of which HLA (Human Leukocyte Antigen) is estimated to contribute for 40-50% to disease 
development [4,5]. In particular, while roughly 95% of CD patients carry HLA-DQ2 
(DQA1*0501/DQB1*0201), most individuals that are not HLA-DQ2 positive express HLA-DQ8 
(DQA1*0301/DQB1*0302). Both HLA-DQ2 and HLA-DQ8 have very characteristic peptide binding 
motifs characterized by a preference for hydrophobic and negatively charged amino acids at specific 
positions in peptides resulting mostly from gliadins digestion [6,7], although the coeliac toxicity of 
glutenins becoming increasingly appreciated [8]. 
According to their mobility in lactic acid PAGE (A-PAGE), gliadins can be subdivided into four 
subfractions: α/β-gliadins, γ-gliadins and ω-gliadins, whereas the glutenins consist of low and high 
molecular weight (LMW and HMW) glutenins, the latter being particularly important for the baking 
quality of dough. Gliadins have several unique features that contribute to their immunogenic 
properties. They are extremely rich in proline (P) and glutamine (Q) and, consequently, highly 
resistant to proteolytic degradation within the gastrointestinal tract, since gastric and pancreatic 
enzymes lack post-proline cleaving activities [9]. Additionally, the high glutamine content makes 
gliadins a good substrate for tissue transglutaminase (tTG), an enzyme constitutively expressed in the 
lamina propria playing a role in tissue repair. Under physiological conditions, tTG can also convert 
(during the deamidation process) glutamine into the negatively charged glutamic acid (E), leading to 
enhanced immunogenicity of the resulting modified peptides, which can preferentially bind to HLA-
DQ2 or HLA-DQ8 [10,11]. 
Deamidation is most likely a crucial event in the generation of a full-blown gluten-specific T cell 
response and concomitant CD development. Many gluten peptides with T cell stimulatory capacity Nutrients  2009, 1                                       
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have been identified in the α/β-gliadins,  γ-gliadins and low and high molecular weight   
glutenins [12,13]. 
Recent work has shown that in addition to a gluten specific T cell activation, there is also activity of 
the innate immune system, mediated by interleukin 15 (IL15) [14] which may be invoked by gliadin 
peptides, particularly α-gliadin 31-49 that do not stimulate small intestinal T cells [15] but which cause 
in vitro [16,17] and in vivo coeliac toxicity [10]. In vivo instillation of HMW glutenins caused an early 
release of IL15 in coeliac patients [8]. 
Attempts to generate wheat (and other cereals) with absent or reduced immunogenicity by selective 
breeding or genetic modifications to detoxify gluten by the introduction of amino acid substitutions are 
still in progress. Currently, available wheat varieties are the result of field selections based on several 
criteria including: (i) high yield (based on a system of high inputs, i.e artificial fertilizers); (ii) disease 
resistance and (iii) technological qualities, e.g., bread- or pasta-making qualities; while there is little 
emphasis on taste and nutrition. In the last decades, ancient populations of local varieties have been 
considerably reduced as a result of the “green revolution” and the diffusion of the new varieties of 
wheat. However, some ancient wheats (which have not been subjected to major genetic improvement) 
have recently been re-introduced to prevent the loss of often locally grown grain varieties, maintain 
biodiversity and avoid food allergies or intolerances. In fact it has been suggested that certain varieties 
of ancient wheats would appear to have fewer toxic motifs and therefore might be better suited to be 
introduced into the diets of people who suffer from food intolerances or allergies [18,19]. 
In this regard, the CD-immunogenic properties of gliadins from the ancient wheats Graziella Ra®, 
which appeared on the market a few years ago and was uncharacterized from this point of view, and 
Kamut®, which is considered an ancient relative of durum wheat, have been investigated. To this aim, 
a comparative analysis including one traditional wheat (Senatore Cappelli) and three modern 
accessions (Flaminio, Grazia and Svevo) was carried out. In particular, we investigated the α-gliadin 
peptides p31-49 (LGQQQPFPQQPYPQPQPF) and p56-75 (LQLQPFPQPQLPYPQPQLPY) - a T cell 
stimulatory epitope whose core region (underlined) is toxic for coeliac patients as a result of tTG 
deamidation (PQLPY→PELPY) - by ELISA and Western Blot using two specific monoclonal 
antibodies (mAbs). Moreover, for all the accessions, α-gliadin genes, once cloned and sequenced, were 
analysed to assess their variability and search for toxic motifs into the corresponding deduced amino 
acid sequences. 
 
2. Results and Discussion  
 
In order to investigate whether α-gliadins from the ancient wheats Graziella Ra® and Kamut® 
would contain the two main toxic peptides (p31-49: LGQQQPFPQQPYPQPQPF; and p56-75: 
LQLQPFPQPQLPYPQPQLPY) related to CD, we compared them to a traditional strain (Senatore 
Cappelli) and to three modern varieties (Flaminio, Grazia and Svevo), usually employed in pasta- or 
bread-making, by two complementary approaches: α-gliadin peptides analysis performed by standard 
proteomic techniques (ELISA and Immunoblotting); and molecular analysis based on α-gliadin  
gene sequencing. Nutrients  2009, 1                                       
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ELISA 
 
In a preliminary step we assessed the amount of total gliadin in all the accessions using a 
commercially available gluten test kit (Gliadin ELISA kit, Immunotech, Czech Republic). For each 
sample, total gliadin content (mg/Kg) was calculated accordingly to the formula reported in 
manufacturer’s instructions (for details see the Experimental section). As shown in Figure 1, Kamut® 
(41.40 g/Kg) and Graziella Ra® (40.43 g/Kg) kernels had the greater amounts of gliadin, followed by 
Senatore Cappelli (30.32 g/Kg), Flaminio (26.80 g/Kg), Svevo (23.46 g/Kg) and Grazia (23.04 g/Kg). 
Figure 1. Total gliadin determination by a two step sandwich ELISA. All values are 
reported as mean ± SD from three independent experiments. 
 
Subsequently, we tested each gliadin extract against the PN3 and CDC-5 mAbs, using gliadin from 
Sigma-Aldrich (UK) as a standard for quantitative analysis. As illustrated in Figures 2 and 3, our 
experiments showed an antigen-antibody positive reaction in every single case. Analyses gave similar 
outcomes for both mAbs. Particularly, two subsets could be evidenced, the first of which grouping 
Graziella Ra® and Kamut®, quite rich in toxic peptides, and the second consisting of the remaining 
relatively poorer accessions. Noteworthily, Senatore Cappelli confirmed to give an antibody positive 
reaction stronger than the three modern cultivars under study.  
Figure 2. A-gliadin peptide p31-49 (LGQQQPFPPQQPYPQPQPF) quantitative 
determination by PN3 mAb. All values are reported as mean ± SD from three independent 
experiments.  
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Figure 3. A-gliadin peptide p56-75 (LQLQPFPQPQLPYPQPQLPY) quantitative 
determination by CDC-5 mAb. All values are reported as mean ± SD from three 
independent experiments. 
 
Western Blot 
SDS-PAGE and Western Blot of α-gliadin from each accession with PN3 and CDC-5 (data not 
shown) mAbs gave similar patterns showing thicker signals in correspondence of the two ancient 
wheats, confirming ELISA results (Figure 4). 
Figure 4. Immunoblotting of α-gliadin extracts with PN3 mAb. M: Prestained Protein 
Marker (New England Biolabs); C: Senatore Cappelli; F: Flaminio; Gr: Grazia; Gll: 
Graziella Ra®; K: Kamut®; S: Svevo; St: Standard Gliadin (Sigma-Aldrich). 
 
Α-Gliadin Gene Sequences Description and Variability  
 
Α-gliadin genes from all the accessions were cloned and sequenced. On the whole for all the 
accessions under study we characterised several alleles, broadly grouped into two subsets, identified as 
short (S) or long (L), respectively. S alleles ranged from 828 bp to 867 bp, while L alleles were Nutrients  2009, 1                                       
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between 894 bp and 963 bp. Every accession showed at least one allele of each type. Moreover, 
several α-gliadin alleles containing one or more internal stop codons were observed. In line with 
previous studies, we referred to them as pseudogenes, although we cannot predict from the genomic 
data whether a subset is being expressed [20]. All sequences have been submitted to GenBank 
database (GQ999806-GQ999831) (Table 1). 
Table 1. Number of obtained unique full Open Reading Frame (ORF) and sequences with 
one or more stop codons (pseudogenes) from wheats under study. GenBank accession 
numbers are reported between brackets. 
Wheat accessions  Full-ORF  Pseudogenes  Total 
Senatore Cappelli  2 (GQ999806-GQ999807)  3 (GQ999818-GQ999820)  5 
Flaminio  2 (GQ999808-GQ999809)  1 (GQ999821)  4 
Grazia  2 (GQ999810-GQ999811)  2 (GQ999822-GQ999823)  4 
Graziella  2 (GQ999812-GQ999813)  2 (GQ999824-GQ999825)  4 
Kamut  2 (GQ999814-GQ999815)  3 (GQ999829-GQ999831)  6 
Svevo  2 (GQ999816-GQ999817)  3 (GQ999826-GQ999828)  5 
Total 12  14  26 
 
The  α-gliadin L genes alignment showed five different haplotypes (Flaminio_L and Kamut_L 
clustered together), defined by 79 polymorphic sites (S = 79) including 80 substitutions (Eta = 80, 56 
transitions and 24 transversions) and 69 insertions/deletions. Parsimony informative sites = 11. 
Haplotype diversity (Hd) was 0.933 ± 0.122. Nucleotide diversity (π) was 0.032 ± 0.011 and 0.033 
when corrected according to Jukes and Cantor (πJC). The average number of nucleotide differences (k) 
was 28.800. Assessed sequence similarity was 89%. Tajima’s D was −1.148, p > 0.10 (not significant), 
hence the null hypothesis of neutral evolution of these DNA sequences was not rejected. Tajima's D is 
a statistical test created to distinguish between a DNA sequence evolving randomly and one evolving 
under a non-random process (under selection). A randomly evolving DNA sequence contains 
mutations with no effect on the fitness and survival of an organism. The randomly evolving mutations 
are called "neutral", while mutations under selection are "non-neutral". Tajima’s test of neutrality is 
based on the fact that under the neutral model estimates of the number of segregating/polymorphic 
sites and of the average number of nucleotide differences are correlated. If the value of D is too large 
or too small, the neutral 'null' hypothesis is rejected. 
The α-gliadin S genes alignment showed six different haplotypes, defined by 149 polymorphic sites 
(S = 149) including 149 substitutions (Eta = 149, 98 transitions and 51 transversions) and 63 
insertions/deletions. Parsimony informative sites = 48. Haplotypes revealed to be restricted to unique 
accessions. Haplotype diversity (Hd) was 1.000 ± 0.096. Nucleotide diversity (π) was 0.074 ± 0.012 
and 0.079 when corrected according to Jukes and Cantor (πJC). The average number of nucleotide 
differences (k) was 60.600. Assessed sequence similarity was about 83%. Tajima’s D was −0.462,  
p > 0.10 (not significant), hence the null hypothesis of neutral evolution of these DNA sequences was  
not rejected. 
Finally, each allele was translated (with a BioEdit dedicated option) into the corresponding protein. 
Proteins alignment was analysed searching for the two epitope motifs which were found in all deduced Nutrients  2009, 1                                       
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amino acid sequences. Moreover, for all examined isoforms, another PQQPY string, whose 
immunogenic significance should be further investigated, was detected (Figure 5). 
Figure 5. Alignment of deduced L and S α-gliadin isoforms of each wheat accession. 
Epitopes recognized by PN3 (yellow highlighted) and CDC-5 (green highlighted) mAbs 
are shown. An additional PQQPY motif (blue highlighted) is indicated. 
 
 
A phylogenetic analysis of the translated full-ORF (Open Reading Frame) α-gliadin genes 
demonstrated a clustering of the sequences according to their genome of origin. Indeed, by comparison 
to diploid ancestors, T. monococcum (A genome) and T. speltoides (closely related to B genome), the 
analysed sequences formed two separate clusters (subtrees) of relatively closely related isoforms in the 
phylogenetic tree (Figure 6). Nutrients  2009, 1                                       
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Figure 6. Neighbor-Joining tree of α-gliadin deduced amino acid sequences. The optimal 
tree with the sum of branch length = 0.533 is shown. The percentage of replicate trees in 
which the associated taxa clustered together in the bootstrap test (1,000 replicates) are 
shown next to the branches. The evolutionary distances were computed using the Poisson 
correction method and are in the units of the number of amino acid substitutions per site. 
All positions containing gaps and missing data were eliminated from the dataset (Complete 
deletion option). L and S refer to long and short deduced amino acid sequences; Tspelt: 
Triticum speltoides; Tmono: Triticum monococcum. 
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In the present study we characterized α-gliadin from Graziella Ra® and Kamut®, in order to 
investigate the controversial hypothesis suggesting ancient grains might show lower immunogenic 
properties and therefore the possibility to introduce them in the diet of wheat-sensitive people, 
including coeliac patients. 
By using a commercially available gluten test kit, we determined that Graziella Ra® and Kamut® 
have relatively greater amount of α-gliadin when compared with the other accessions under study. 
Taking into account that gluten represents about 80% of the entire protein reservoir in wheat and that it 
is composed by gliadins and glutenins, present results would validate the producers’ claims that 
ancient wheats are endowed with kernels usually bigger and richer in proteins than common wheats. 
Interestingly, Senatore Cappelli showed an amount of α-gliadin that is in-between ancient and modern 
accessions, which supports the placing it as a traditional (i.e., the first selected) wheat. 
When employing a two step indirect ELISA with PN3 and CDC-5, specifically raised against   
p31-49 and p56-75, similar patterns were observed for both mAbs. Our data demonstrate the 
occurrence of the two peptides in all the accessions analysed. In particular, Graziella Ra® and 
Kamut® showed the highest values, in contrast with the “low immunogenicity” hypothesis. Such Nutrients  2009, 1                                       
 
 
284
findings were also confirmed by immunoblotting, as revealed by marked hybridization signals located 
on Graziella Ra® and Kamut® lanes in developed films (see Figure 4). 
As far as molecular analysis is concerned, the occurrence of two alleles of different sizes (L and S 
type) for each accession, is in line with the relatively high number of α-gliadin alleles reported for 
diploid wheat ancestors (T. speltoides and T. monococcum) and hexaploid (T. aestivum) species [21]. 
Observed L and S alleles differ from each other, at least in this case, mostly in the length of few  
CAA-rich regions. The amplification of α-gliadin alleles from A or B genome employing the same 
primers pair can be considered as a result of the typical structure of the gene. Indeed, the fact that the 
sequences at the 5' end (signal peptide) and 3' end of the genes are highly conserved enables to obtain 
different members of the gene family when using a PCR-based approach. Moreover, we encountered 
also a consistent percentage of pseudogenes all showing the C→T substitution as the most common 
single-base change, contributing to the generation of stop codons. Such findings agree with previous 
observations that at least 50% of the α-gliadin genes are pseudogenes [21,22]. Interestingly, Tajima’s 
test results seem to suggest that analysed α-gliadin genes mainly undergone neutral evolution. To 
better investigate the nature of evolutive forces, we computed the number of synonymous (Ks) and 
non-synonymous (Ka) substitutions per site for all full ORF and pseudogene obtained sequences. A 
synonymous (or silent) substitution is the substitution of one base for another in an exon of a gene, 
such that the amino acid sequence produced is not modified. Otherwise, a non synonymous 
substitution results in an altered sequence in a polypeptide or functional RNA. In the study of 
evolution, DNA sequences are more informative than protein sequences since a large part of DNA is 
not translated and there is degeneracy of the genetic code. Furthermore, according to King and   
Jukes [23,24] because of degeneracy of the genetic code, a certain proportion of nucleotide 
substitutions in protein-coding genes are expected to be silent and result in no amino acid 
substitutions; and, since synonymous substitutions should be neutral, Ks rate should be higher than Ka 
rate if neutral theory is correct. Noteworthy, the mean Ka/Ks ratio for the full ORFs was lower than that 
of the pseudogenes (0.368 ± 0.006 vs 0.417 ± 0.116), thus demonstrating the occurrence of a 
statistically significant (t test, p < 0.05) excess of synonymous substitutions in genes when compared 
to pseudogenes. These findings are in line with the neutral evolution hypothesis as also suggested by 
Tajima’s test results. 
When analysing the deduced amino acid sequences we found a high degree of similarity (about 
75% and 86% for S and L deduced isoforms, respectively). Moreover, the p31-49 and p56-75 epitopes 
occurred in all proteins and, although slightly modified (due to a few amino acid substitutions) with 
respect to available GenBank sequences (ABB92632; ABB92633; CAI35909), they constantly showed 
highly conserved toxic core regions (PQQPY; PQLPY). The antibody PN3 has been shown to bind in 
the region QQQPFP  of the peptide p31-49. This peptide does not have small intestinal T cell 
stimulatory properties, but has been shown active to the innate immune system in coeliac patients [17] 
and to be toxic in vivo [10]. The exact sequence within the T cell stimulating peptide p56-75 identified 
by the antibody CDC-5 is not known at present. However, although further studies to analyse T cell 
clone reactivity would be of importance, the association of proteomic (ELISA and Immunoblotting) 
and genomic (molecular analysis) investigations, demonstrated the potential high immunogenicity and 
toxicity to CD patients of all the accessions under study, including the two ancient wheats.  
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3. Experimental Section  
 
Wheat Accessions 
 
Graziella Ra® is an ancient durum wheat (Triticum turgidum durum), organically grown only in the 
Marche region by the Alce Nero Cooperative (Isola del Piano, PU, Marche region, Italy), that appeared 
on the market a few years ago due to its good taste and fine pasta-making quality. It derived from 
kernels taken from an Egyptian tomb and was brought to Italy in the late 70’s (Graziella Ra® history is 
fully reported at http://www.alcenerocooperativa.it). Up to now, Graziella Ra® genome has never been 
characterized; hence, the analysis of the CD-immunogenic properties of its α-gliadin appeared to be a 
very intriguing issue.  
Kamut® is an ancient type of wheat related to the durum subspecies. At present its systematics is 
still uncertain. In fact, originally, it was classified as Triticum turgidum polonicum (Polish wheat), but 
also suggested by some to be Triticum turgidum turanicum (oriental or Khurasan wheat), or being in 
fact Triticum turgidum durum (durum wheat). Due to its ancient origin and easy availability, Kamut® 
was chosen to be compared to Graziella Ra®. For the present study, a small amount (100 g) was 
kindly provided by “Molini del Conero by Agriconero Srl” (Osimo, AN, Italy). 
Grazia, Flaminio, Svevo (modern varieties) and Senatore Cappelli (a traditional strain, namely the 
first “chosen” variety selected by N. Strampelli) are all Triticum turgidum durum and were provided 
by “Alce Nero Cooperative” (Isola del Piano, PU, Italy). 
 
Gliadin Extraction 
 
For each accession, wheat kernels were ground in an electric grinder to produce a homogenous 
sample powder. Subsequently, gliadins were extracted following standard protocols: briefly, 1 g of 
powder was transferred to 10 mL of 60% (v/v) ethanol for 30 min, shaking vigorously. After 
centrifugation (3,000 g x 15 min) at room temperature (RT), the supernatant was recovered and stored 
frozen (−20 °C). As a standard, whole gliadin from Sigma-Aldrich (G3375) was chosen because it 
compares well to the European gliadin standard [25]. 
 
Monoclonal Antibodies 
 
To determine α-gliadin amount in extracts from all accessions and in Sigma gliadin, two 
monoclonal antibodies (mAbs), PN3 and CDC-5, were used. The PN3 mAb [26] was raised against a 
synthetic peptide equivalent to the amino acids 31-49 (LGQQQPFPPQQPYPQPQPF) of α-gliadin, 
which has been shown to cause mucosal damage to the small bowel of coeliac patients, both in vivo 
and in vitro [10,16,17]. This mAb was used at 1:800 and 1:1,000 dilutions in Western Blot and Indirect 
ELISA, respectively. 
CDC-5 mAb [27] was raised against a synthetic peptide equivalent to the amino acids 56–75 
(LQLQPFPQPQLPYPQPQLPY) of α-gliadin, which has been indicated as highly immunogenic in 
adult coeliac patients. CDC-5 was used at 1:1,500 and 1:2,000 dilutions in Western Blot and Indirect 
ELISA, respectively. Nutrients  2009, 1                                       
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Enzyme-Linked ImmunoSorbent Assay (ELISA) 
 
For each accession, total gliadin was assessed by a commercial two immunological step sandwich 
assay type, the Gliadin ELISA kit (IM3717, Immunotech, Czech Republic) accordingly to the 
manufacturer’s instructions.  
Subsequently,  α-gliadin was determined by indirect two-steps ELISA following standard 
procedures [28]. Briefly, 96-microwells plates were coated with samples (diluted 1:3,000) and 
standards (Sigma gliadin at concentrations ranging from 0 ng/mL to 1000 ng/mL) overnight at 4 °C in 
the dark, incubated with murine monoclonal antibodies (PN3 or CDC-5) for one hour and goat anti-
mouse immunoglobulin (IgG, H + L) conjugated to horseradish peroxidase (Pierce Biotechnology, 
USA) diluted 1:5,000, for one hour. The substrate, tetramethylbenzidine (TMB), was added to plates 
and left 15 minutes at RT in the dark. Finally the absorbance at 450 nm was determined using an 
ELISA plate reader (SunriseII, Tecan, Italy). 
Results were read off a semi-logarithmic calibration curve, constructed as the dependence of 
measured absorbance values (vertical axis - linear scale) of corresponding calibrators (standard Sigma-
gliadin), range 0–1,000 ng/mL (horizontal axis – logarithmic scale). For each extract, concentrations 
were recalculated to the content of gliadin expressed in mg/Kg of dry substance according to   
the formula: 
C[mg/Kg]=[Ckk (ng/mL) x extract_volume (mL) x dilution_factor] / [1,000 x dry_substance_rate x 
weight (g)] 
where Ckk, concentration reading at 450 nm; dry_substance_rate = 0.9 (i.e., 90% of dry substance  
in sample).   
 
SDS-PAGE and Western Blot 
 
Whole gliadins (10 mg/mL each) from experimental wheats and Sigma gliadin (1 mg/mL) were 
separated by SDS-PAGE on a 12.5% acrylamide gel in reducing condition [29]. Afterwards, proteins 
were transferred on a 0.45 μm nitrocellulose membrane (Whatman, Germany), incubated with CDC-5 
or PN3 monoclonal antibodies, diluted 1:800 and 1:400 respectively, and visualized with goat anti-
mouse immunoglobulin (IgG, H + L) labelled with horseradish peroxidase (Pierce Biotechnology, 
USA) diluted 1:20,000, using SuperSignal West Pico Chemiluminescence Substrate (Pierce 
Biotechnology, USA).  
 
DNA Extraction, Amplification, Cloning and Sequencing 
 
Fifteen seeds of each cultivar germinated in the dark for two days. The seedlings were grown in 
daylight for seven days. The leaf tissues - sampled at the four-leaf stage from ten different plants per 
accession – were immediately frozen in liquid nitrogen and ground in a mortar with a pestle. 50 mg of 
powder was used for DNA extraction following the cetyltrimethylammonium bromide (CTAB) buffer 
protocol with slight modifications [30]. DNA quality was tested by 0.8% agarose gel electrophoresis. Nutrients  2009, 1                                       
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Primers to amplify α-gliadin genes from genomic DNA using PCR, were designed on the conserved 
sequences at the 5’ and 3’ end of the coding region of the α-gliadin gene sequences obtained from the 
GenBank database (DQ296195, DQ296196 and AJ870965): 
forward primer: 5’- ATG AAG ACC TTT CTC ATC C – 3’ 
reverse primer: 5’- YYA GTT RGT ACC GAA GAT GCC – 3’ 
PCR amplification was carried out using an automated DNA thermal cycler (ThermoHybaid, 
Celbio, Italy) and a high fidelity Pfu DNA Polymerase (Promega, Madison, WI, USA) as follows:  
95 °C for 2 min; 95 °C for 1 min, 60 °C for 30 sec, 72 °C for 2 min (30 cycles); 72 °C for 5 min. The 
reaction product was visualized by electrophoresis on a 1.2% agarose gel containing tris-borate-EDTA 
buffer and ethidium bromide (0.5 μg/mL). An aliquot (1 μL) of the PCR product was inserted into a 
pCR 4-TOPO vector by the TA-cloning system and transformation was performed on Escherichia coli 
TOP10 cells following the manufacturer’s instructions (Invitrogen, Carlsbad, CA, USA). The selected 
transformants were analysed for presence and correct orientation of the insert by PCR, grown in LB 
medium overnight and purified by the Wizard Plus SV minipreps kit (Promega). Finally, sequencing of 
plasmid inserts was done by using automated DNA sequencers at Eurofins MWG Operon (Germany). 
Sequences were visualized with BioEdit Sequence Alignment Editor version 7.0.5.3 [31], aligned 
with the ClustalW option included in this software and double checked by eye. Standard measures of 
nucleotide polymorphism [haplotype diversity (Hd), mean pairwise differences (k), nucleotide 
diversity (π)] and Tajima’s test of neutrality [32] were computed using DNAsp version 5 [33]. 
Deduced amino acid sequences were obtained and analysed by BioEdit dedicated options. 
Phylogenetic analysis of α-gliadin deduced amino acid sequences alignment were performed using 
MEGA version 4.0.2 [34]. The evolutionary distances were computed using the Poisson correction 
method [35] and are in the units of the number of amino acid substitutions per site. All positions 
containing gaps and missing data were eliminated from the dataset (Complete deletion option). 
Phylogenetic trees were reconstructed using the Neighbour-Joining procedure [36]. Support for the 
internodes was assessed by bootstrap percentages [37] after 1,000 resampling steps. Α-gliadin deduced 
amino acid sequences were compared to deduced amino acid sequences of homologous genes from 
diploid species that represent the ancestral genomes of durum wheat, T. monococcum (A genome) and 
T. speltoides (considered as very close to the ancestor of B genome) available in GenBank database 
(DQ002569-DQ002570; DQ002584-DQ002585). Statistical analysis was performed by a two tailed t 
test for independent data. 
 
4. Conclusions  
 
In this study we aimed to test whether α-gliadin from two ancient wheats could be considered less 
“toxic” for coeliac patients. Our results demonstrate that (i) the ancient wheats Graziella Ra® and 
Kamut® have greater amounts of α-gliadin than modern accessions; (ii) α-gliadins from such ancient 
wheats show a strong and specific binding reaction to anti-p31-49 and anti-p56-75 mAbs, thus 
suggesting the occurrence of epitopes with proven coeliac toxicity; (iii) α-gliadins from ancient and 
modern wheat accessions analysed share common features and properties both from immunological Nutrients  2009, 1                                       
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and molecular point of view. In conclusion, we suggest that Graziella Ra® and Kamut® are potentially 
as toxic as modern wheats with reference to CD and, therefore, although clinical trials are still 
necessary, we strongly recommend that they should not be introduced in the diet of coeliac patients. 
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